CurrentEndo
Get Weekly

Topic · page 71 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 2,801–2,840 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabetes Care

    Dulaglutide and Glomerular Hyperfiltration, Proteinuria, and Albuminuria in Youth With Type 2 Diabetes: Post Hoc Analysis of the AWARD-PEDS Study

    Secondary analysis

  2. J Clin Endocrinol Metab

    Dynamic Response of Musclin, a Myokine, to Aerobic Exercise and Its Interplay With Natriuretic Peptides and Receptor C

    Mechanistic study

  3. Diabetes Obes Metab

    Metformin monotherapy versus predominantly older non‐metformin antidiabetic medications for cerebrovascular risk in early type 2 diabetes management

    Cohort study

  4. JAMA Intern Med

    Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial

    Randomized controlled trial

  5. JAMA Netw Open

    Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes

    Cohort study

  6. Diabetes Obes Metab

    Incretin‐based therapy and the risk of diabetic foot ulcers and related events

    Cohort study

  7. Diabetes Obes Metab

    Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials

    Meta-analysis

  8. JAMA Netw Open

    Patient Out-of-Pocket Costs for Type 2 Diabetes Medications When Aging Into Medicare

    Cohort study

  9. Diabetes Obes Metab

    Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes

    Randomized controlled trial

  10. Diabetes Metab

    Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study

    Cohort study

  11. Diabetes Metab

    Associations of dietary magnesium intake with the risk of atherosclerotic cardiovascular disease and mortality in individuals with and without type 2 diabetes: A prospective study in the UK Biobank

    Cohort study

  12. Diabetes Res Clin Pract

    Can the postload-fasting glucose gap be used to determine risk of developing diabetes in chinese adults: A prospective cohort study

    Cohort study

  13. Cardiovasc Diabetol

    Nonlinear association between atherogenic index of plasma and type 2 diabetes mellitus in overweight and obesity patients: evidence from Chinese medical examination data

    Cross-sectional study

  14. Diabetes Care

    SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study

    Randomized controlled trial

  15. Cardiovasc Diabetol

    Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial

    Randomized controlled trial

  16. Cardiovasc Diabetol

    Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure

    Cross-sectional study

  17. Diabetes Res Clin Pract

    Impact of hospital-community diabetes management intervention in Central Region, Ghana: A retrospective study

    Cohort study

  18. BMJ Open Diabetes Res Care

    Predictors of readmission and mortality in adults with diabetes or stress hyperglycemia after initial hospitalization for COVID-19

    Cohort study

  19. BMJ Open Diabetes Res Care

    Unveiling contrasts in microbiota response: A1c control improves dysbiosis in low-A1c T2DM, but fails in high-A1c cases—a key to metabolic memory?

    Cohort study

  20. Diabetes Care

    Circulating Metabolite Biomarkers of Glycemic Control in Youth-Onset Type 2 Diabetes

    Secondary analysis

  21. Diabetes Care

    Age of Diabetes Diagnosis and Lifetime Risk of Dementia: The Atherosclerosis Risk in Communities (ARIC) Study

    Cohort study

  22. Diabetologia

    Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans

    Cohort study

  23. Cardiovasc Diabetol

    Empagliflozin’s role in reducing ventricular repolarization heterogeneity: insights into cardiovascular mortality decline from the EMPATHY-HEART trial

    Research article

  24. BMJ

    SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study

    Cohort study

  25. Diabetes Res Clin Pract

    Prediction of the 10-year incidence of type 2 diabetes mellitus based on advanced anthropometric indices using machine learning methods in the Iranian population

    Cohort study

  26. Diabetes Care

    Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

    Cohort study

  27. Diabetes Care

    The Association Between Depressive Symptoms, Access to Diabetes Care, and Glycemic Control in Five Middle-Income Countries

    Cross-sectional study

  28. Nat Med

    Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes

    Cohort study

  29. Diabet Med

    Participation in Special Olympics reduces the rate for developing diabetes in adults with intellectual and developmental disabilities

    Cohort study

  30. Diabetes Obes Metab

    Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials

    Meta-analysis

  31. Diabetes Obes Metab

    Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data

    Secondary analysis

  32. Diabet Med

    Healthcare professionals' competencies and confidence in managing hospitalized patients with type 2 diabetes

    Cross-sectional study

  33. Diabetes Res Clin Pract

    Age of type 2 diabetes onset as a risk factor for dementia: A 13-year retrospective cohort study

    Cohort study

  34. Diabetes Res Clin Pract

    Tirzepatide use and the risk of cancer among individuals with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials

    Meta-analysis

  35. Diabetes Res Clin Pract

    Lower achievement of guideline recommended care in Canadian adults with early-onset diabetes: A population-based cohort study

    Cohort study

  36. Diabetes Care

    Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999–2019 National Medicare Claims

    Cohort study

  37. J Clin Endocrinol Metab

    Association of Age at Menarche With Inflammation and Glucose Metabolism Biomarkers in US Adult Women: NHANES 1999-2018

    Cross-sectional study

  38. Diabetes Care

    The Gut Microbiota and Diabetes: Research, Translation, and Clinical Applications—2023 Diabetes , Diabetes Care , and Diabetologia Expert Forum

    Guideline or statement

  39. Diabetologia

    The gut microbiota and diabetes: research, translation, and clinical applications – 2023 Diabetes, Diabetes Care, and Diabetologia Expert Forum

    Guideline or statement

  40. Diabetes Metab

    Association of multiple sclerosis with incident diabetes: A nationwide cohort study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 2,801–2,840 of 4,758, newest first